Keratoconus management has significantly changed over the last two decades. The advent of new interventions such as cornea cross-linking, intrastromal corneal ring segments, and combined treatments provide corneal clinicians a variety of treatment options for the visual rehabilitation of keratoconus patients. This review summarizes current evidence for these treatments and highlights their place in keratoconus management while new promising emerging therapies are being investigated
Background: The KERALINK trial tests the hypothesis that corneal cross-linking (CXL) treatment reduc...
Thesis (M.A.)--Boston UniversityKeratoconus is a non-inflammatory thinning of the cornea that can le...
Keratoconus (KC) is a common bilateral, non-inflammatory, and progressive ectatic disease of the cor...
Keratoconus management has significantly changed over the last two decades. The advent of new interv...
AbstractKeratoconus is a common corneal ectatic disorder which affects approximately 1 in 2,000 peop...
Background Modern keratoconus monitoring and management centres around tomography. Large scale st...
The focus of the present review of literature is keratoconus, a progressive thinning of the cornea. ...
Background: Corneal cross-linking is widely used to treat keratoconus. However, to date, only limite...
Keratoconus is a slowly progressive, noninflammatory ectatic corneal disease characterized by change...
PURPOSE: To examine the efficacy and safety of corneal cross-linking (CXL) for stabilization of prog...
Background: The purpose of this study was to identify differences in clinical corneal findings after...
Keratoconus is a bilateral and asymmetric disease which results in progressive thinning and steeping...
Keratoconus is a bilateral and asymmetric disease which results in progressive thinning and steeping...
Background: The KERALINK trial tests the hypothesis that corneal cross-linking (CXL) treatment reduc...
Thesis (M.A.)--Boston UniversityKeratoconus is a non-inflammatory thinning of the cornea that can le...
Keratoconus (KC) is a common bilateral, non-inflammatory, and progressive ectatic disease of the cor...
Keratoconus management has significantly changed over the last two decades. The advent of new interv...
AbstractKeratoconus is a common corneal ectatic disorder which affects approximately 1 in 2,000 peop...
Background Modern keratoconus monitoring and management centres around tomography. Large scale st...
The focus of the present review of literature is keratoconus, a progressive thinning of the cornea. ...
Background: Corneal cross-linking is widely used to treat keratoconus. However, to date, only limite...
Keratoconus is a slowly progressive, noninflammatory ectatic corneal disease characterized by change...
PURPOSE: To examine the efficacy and safety of corneal cross-linking (CXL) for stabilization of prog...
Background: The purpose of this study was to identify differences in clinical corneal findings after...
Keratoconus is a bilateral and asymmetric disease which results in progressive thinning and steeping...
Keratoconus is a bilateral and asymmetric disease which results in progressive thinning and steeping...
Background: The KERALINK trial tests the hypothesis that corneal cross-linking (CXL) treatment reduc...
Thesis (M.A.)--Boston UniversityKeratoconus is a non-inflammatory thinning of the cornea that can le...
Keratoconus (KC) is a common bilateral, non-inflammatory, and progressive ectatic disease of the cor...